Cardiovascular-Kidney-Metabolic (CKM) Syndrome Staging and Relevance to Precision Nutrition. [PDF]
Background/Objectives: It is estimated that one in three adults in the US has one or more risk factors for cardiovascular–kidney–metabolic (CKM) syndrome. The American Heart Association (AHA) has warned that the interaction between obesity, Type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular disease (CVD) leads to a multistage CKM ...
Soliman GA.
europepmc +2 more sources
Association Between Serum Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A 3-Year Longitudinal Cohort Study (2019-2022). [PDF]
Zhao H +16 more
europepmc +3 more sources
Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic (CKM) Syndrome. [PDF]
The cardiovascular–kidney–metabolic (CKM) syndrome was recently conceptualized to provide a holistic framework for diagnosing and treating the full spectrum of key age-associated interrelated conditions: overweight/obesity, type 2 diabetes mellitus, acute and chronic kidney disease, and cardiovascular disease.
Guerrero-Mauvecin J +8 more
europepmc +5 more sources
Associations between the CHG index, its modified versions and incident stroke in patients with early-stage CKM syndrome: a nationwide cohort study [PDF]
Ke L, Li Y, Jiang S, Xing W, Zhao L.
exaly +2 more sources
TyG and RC combined with CVD risk in CKM syndrome: A national cohort study. [PDF]
Lan H +6 more
europepmc +2 more sources
Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Case-Based Narrative Review. [PDF]
These 4 hypothetical cases highlight new features of the American Heart Association cardiovascular-kidney-metabolic (CKM) health construct. The cases incorporate the CKM staging system, estimates from the PREVENT risk calculator, and clinical approaches related to CKM stages and individual risk profiles. Topics include management considerations for (1)
Javaid A +8 more
europepmc +4 more sources
Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) [PDF]
Yixuan Zhu, Shanghao Liu, Fajuan Rui
exaly +2 more sources
Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular–kidney–metabolic (CKM) syndrome stages 0–3: a prospective cohort study of 282,920 participants in the UK Biobank [PDF]
Yueqing Huang
exaly +2 more sources
Background In 2023, the American Heart Association defined the concept of cardiovascular–kidney–metabolic (CKM) syndrome as a health disorder ascribed to connections among obesity, diabetes, chronic kidney disease, and cardiovascular disease.
Dingyuan Tu +4 more
doaj +1 more source
ObjectiveTo explore the correlation between the triglyceride glucose-waist-to-height ratio (TyG-WHtR) and advanced cardiovascular-kidney-metabolic (CKM) syndrome.
Xingxing REN
doaj +1 more source

